e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Biological and molecular features in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Potentiality of detectionof microsatellite alterations in exhaled breath condensate of smokers as a tool for tumor susceptibility
G. E. Carpagnano, M. P. Foschino Barbaro, S. Tommasi, O. Resta, F. Carpagnano, G. Di Gioia, M. De Lena, A. Paradiso (Foggia, Bari, Italy)
Source:
Annual Congress 2005 - Biological and molecular features in lung cancer
Session:
Biological and molecular features in lung cancer
Session type:
Thematic Poster Session
Number:
2153
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. E. Carpagnano, M. P. Foschino Barbaro, S. Tommasi, O. Resta, F. Carpagnano, G. Di Gioia, M. De Lena, A. Paradiso (Foggia, Bari, Italy). Potentiality of detectionof microsatellite alterations in exhaled breath condensate of smokers as a tool for tumor susceptibility. Eur Respir J 2005; 26: Suppl. 49, 2153
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
Reproducibility of exhaled breath condensate markers
Source: Eur Respir J 2008; 32:
Year: 2008
Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1036-1041
Year: 2006
Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005
Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006
3p microsatellite evaluation in NSCLC exhaled breath condensate: validation study
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
The validation of assays used to measure biomarkers in exhaled breath condensate
Source: Eur Respir J 2008; 32: 1408-1409
Year: 2008
Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification
Source: Eur Respir J 2007; 30: Suppl. 51, 364s
Year: 2007
Standardization of collection of exhaled breath condensate (EBC) for disease markers in use of different condensers
Source: Eur Respir J 2003; 22: Suppl. 45, 448s
Year: 2003
Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes.
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002
Exhaled biomarkers in lung cancer
Source: Eur Respir J 2009; 34: 261-275
Year: 2009
Exhaled breath condensate sample collection: standards and open issues
Source: Eur Respir Monogr 2010; 49: 152-161
Year: 2010
Exhaled breath condensate is not suitable to detect EGFR somatic mutations
Source: Eur Respir J 2008; 32: 1123-1124
Year: 2008
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008
Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 283s
Year: 2006
Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition?
Source: Eur Respir J 2004; 24: Suppl. 48, 386s
Year: 2004
Proteins in exhaled breath condensate: identification and pattern
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Year: 2007
Comparison of two devices and two breathing patterns for exhaled breath condensate sampling
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Structures of an exhaled breath condensate in lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 525s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept